Patents Assigned to ORAMED LTD.
  • Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
    Publication number: 20240181018
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of norialcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Application
    Filed: December 21, 2023
    Publication date: June 6, 2024
    Applicant: ORAMED LTD.
    Inventors: Miriam KIDRON, Ehud ARBIT
  • METHODS AND COMPOSITIONS FOR TREATING DIABETES
    Publication number: 20230210956
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: June 29, 2022
    Publication date: July 6, 2023
    Applicant: ORAMED LTD.
    Inventor: MIRIAM KIDRON
  • Methods and compositions for treating diabetes
    Patent number: 11395848
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: July 26, 2022
    Assignee: ORAMED LTD.
    Inventor: Miriam Kidron
  • Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
    Publication number: 20220000986
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Application
    Filed: March 19, 2021
    Publication date: January 6, 2022
    Applicant: ORAMED LTD.
    Inventors: Miriam KIDRON, Ehud ARBIT
  • Methods and Compositions for Treating Diabetes
    Publication number: 20210077588
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: March 23, 2020
    Publication date: March 18, 2021
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • Methods and Compositions for Treating Diabetes
    Publication number: 20190374615
    Abstract: Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a GLP-1 analogue.
    Type: Application
    Filed: August 27, 2019
    Publication date: December 12, 2019
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
    Publication number: 20190209655
    Abstract: Provided herein are oral pharmaceutical compositions containing a GLP-1 analogue and/or insulin for treating and reducing the incidence of nonalcoholic fatty liver disease (NAFLD), hepatic steatosis, and sequelae thereof, and methods of utilizing same.
    Type: Application
    Filed: November 19, 2018
    Publication date: July 11, 2019
    Applicant: ORAMED LTD.
    Inventors: Miriam Kidron, Ehud Arbit
  • METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF EXENATIDE
    Publication number: 20110046053
    Abstract: This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta.
    Type: Application
    Filed: May 3, 2009
    Publication date: February 24, 2011
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron
  • METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
    Publication number: 20110014247
    Abstract: This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.
    Type: Application
    Filed: February 26, 2009
    Publication date: January 20, 2011
    Applicant: ORAMED LTD.
    Inventor: Miriam Kidron